Neglected Tropical Diseases

Neglected tropical diseases (NTDs) are a diverse group of communicable diseases that prevail in tropical and subtropical conditions in 149 countries. They affect more than one billion people in the poorest and most marginalised communities in the world, and cost developing economies billions of dollars every year reducing overall global prosperity. Populations living in poverty, without adequate sanitation and in close contact with infectious vectors and domestic animals and livestock are those worst affected.

The All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases (APPMG) exists to give the opportunity to Parliamentarians in Westminster and those working in the field of NTDs to understand the many distressing diseases and what is being done to bring them under control and then eliminate them.

The Group provides a forum for the best speakers from around the world, professors, doctors, health workers and NGOs who highlight issues where Parliamentarians and others can learn about new the developments.

Each year the APPMG published a Report on NTDs reflecting on the work of the group and exploring the trends within global development work.

Effective control of NTDs has been successful when selected public health approaches are combined and delivered locally. Interventions are guided by the local epidemiology and the availability of appropriate measures to detect, prevent and control diseases. Implementation of appropriate measures with high coverage will contribute to achieving the targets of the WHO NTD Roadmap on neglected tropical diseases, resulting in the elimination of many and the eradication of at least two by 2020.

The UK Government is a leader in fighting NTDs, and will more than double its support over the next 5 years. This will mean a billion treatments for people at risk in the developing world as part of an international push to eliminate and eradicate these ailments for good. The UK also builds on the great work done by our world-class universities, pharma companies and NGOs tackling Neglected Tropical Diseases by investing in pioneering research to drive the development of drugs that will control or eliminate them.

For more general and specific resources on malaria see: